PT88938A - PROCESS FOR THE PREPARATION OF A NEW VARIANT OF THE HUMAN TISSUE PLASMINOGENEUM ACTIVATOR - Google Patents

PROCESS FOR THE PREPARATION OF A NEW VARIANT OF THE HUMAN TISSUE PLASMINOGENEUM ACTIVATOR

Info

Publication number
PT88938A
PT88938A PT88938A PT8893888A PT88938A PT 88938 A PT88938 A PT 88938A PT 88938 A PT88938 A PT 88938A PT 8893888 A PT8893888 A PT 8893888A PT 88938 A PT88938 A PT 88938A
Authority
PT
Portugal
Prior art keywords
preparation
human tissue
plasminogeneum
activator
new variant
Prior art date
Application number
PT88938A
Other languages
Portuguese (pt)
Other versions
PT88938B (en
Inventor
Adair J Hotchkiss
John V O'connor
Michael W Spellman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of PT88938A publication Critical patent/PT88938A/en
Publication of PT88938B publication Critical patent/PT88938B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Novel human tissue-type plasminogen activator variant that a) retains substantially full biological activity, b) has a modified carbohydrate structure and c) has an altered in vivo half-life. Mains for preparation of the variants and results of assays measuring function of the activators are also disclosed. <IMAGE>
PT88938A 1987-11-06 1988-11-04 PROCESS FOR THE PREPARATION OF A NEW VARIANT OF THE HUMAN TISSUE PLASMINOGENEUM ACTIVATOR PT88938B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11809887A 1987-11-06 1987-11-06

Publications (2)

Publication Number Publication Date
PT88938A true PT88938A (en) 1989-11-30
PT88938B PT88938B (en) 1993-05-31

Family

ID=22376492

Family Applications (1)

Application Number Title Priority Date Filing Date
PT88938A PT88938B (en) 1987-11-06 1988-11-04 PROCESS FOR THE PREPARATION OF A NEW VARIANT OF THE HUMAN TISSUE PLASMINOGENEUM ACTIVATOR

Country Status (18)

Country Link
EP (2) EP0387290B1 (en)
JP (1) JPH03500843A (en)
KR (1) KR920009521B1 (en)
AT (1) ATE151812T1 (en)
AU (2) AU2804989A (en)
CA (1) CA1341609C (en)
DD (1) DD286613A5 (en)
DE (1) DE3855874T2 (en)
DK (1) DK175482B1 (en)
FI (1) FI102970B1 (en)
HU (1) HU215230B (en)
IL (1) IL88247A0 (en)
NO (1) NO307612B1 (en)
NZ (1) NZ226829A (en)
PH (1) PH30064A (en)
PT (1) PT88938B (en)
WO (1) WO1989004368A1 (en)
ZA (1) ZA888250B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0542869T3 (en) * 1990-07-31 1996-02-05 Genentech Inc Tissue plasminogen activator variants with decreased secretion
US5246850A (en) * 1990-07-31 1993-09-21 Genentech, Inc. DNA molecules encoding human tissue plasminogen activator variants with decreased clearance, vectors, and host cells
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
ATE246000T1 (en) 1992-06-03 2003-08-15 Genentech Inc VARIANTS OF TISSUE PLASMINOGEN ACTIVATOR WITH IMPROVED THERAPEUTIC EFFECTS
DE69719265T2 (en) * 1996-09-06 2003-12-04 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute, Kumamoto Medicinal composition containing tissue plasminogen activator and nicotinamide
US7084118B2 (en) 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125254A1 (en) * 1982-10-28 1984-11-21 Beecham Group Plc Enzyme derivatives and their use in the treatment of thrombosis
DE3789664T3 (en) * 1986-01-31 2004-09-16 Genetics Institute, LLC, Cambridge NEW THROMBOLYTIC PROTEINS.
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
IL87276A (en) * 1987-08-03 1995-07-31 Fujisawa Pharmaceutical Co Analog of tissue plasminogen activator comprising only the kringle 2 and protease domain dna encoding the same processes for the preparation thereof and pharmaceutical compositions containing the same
EP0311589B1 (en) * 1987-10-09 1994-03-23 Monsanto Company Modified tissue plasminogen activator

Also Published As

Publication number Publication date
DE3855874T2 (en) 1997-09-11
PH30064A (en) 1996-11-08
EP0754753A1 (en) 1997-01-22
NO307612B1 (en) 2000-05-02
FI902239A0 (en) 1990-05-04
AU2804989A (en) 1989-06-01
FI102970B (en) 1999-03-31
FI102970B1 (en) 1999-03-31
ATE151812T1 (en) 1997-05-15
IL88247A0 (en) 1989-06-30
HU890157D0 (en) 1990-12-28
CA1341609C (en) 2011-02-01
NO901995L (en) 1990-07-05
NZ226829A (en) 1991-06-25
WO1989004368A1 (en) 1989-05-18
DK112290D0 (en) 1990-05-04
HU215230B (en) 2000-03-28
AU658909B2 (en) 1995-05-04
DK112290A (en) 1990-07-06
JPH03500843A (en) 1991-02-28
ZA888250B (en) 1990-07-25
KR920009521B1 (en) 1992-10-17
DD286613A5 (en) 1991-01-31
AU2131792A (en) 1992-11-19
DK175482B1 (en) 2004-11-08
KR890701733A (en) 1989-12-21
PT88938B (en) 1993-05-31
EP0387290A1 (en) 1990-09-19
DE3855874D1 (en) 1997-05-22
EP0387290B1 (en) 1997-04-16
HUT54209A (en) 1991-01-28
NO901995D0 (en) 1990-05-04

Similar Documents

Publication Publication Date Title
DE3751842D1 (en) Modified human tissue plasminogen activator and its manufacture
IL80659A (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
AU6806487A (en) Tissue plasminogen activator
PT88938A (en) PROCESS FOR THE PREPARATION OF A NEW VARIANT OF THE HUMAN TISSUE PLASMINOGENEUM ACTIVATOR
EP0305890A3 (en) Use of bezafibrate for the treatment of diabetes
AU1200488A (en) Protein c inhibitor (pci) as pharmaceutical and in vitro diagnostic aid, a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci
FI902700A0 (en) VAEVNADPLASMINOGENAKTIVATORDERIVAT.
IL109759A0 (en) Human tissue-type plasminogen activator having modified functional carbohydrate residues, which retains its biological activity and is characterized by an increased in vivo half-life
AU7090787A (en) Tissue plasminogen activator
IE870208L (en) Modified tissue plasminogen activator
ES2063106T3 (en) PROCEDURE FOR THE DETERMINATION OF THE ACTIVITY OF THE PLASMINOGEN ACTIVATOR IN SAMPLES CONTAINING ALPHA-2-ANTIPLASMINE.
IE871856L (en) &#34;modified tissue plasminogen activator&#34;
IE861388L (en) Tissue plasminogen activator
GB8718298D0 (en) Tissue plasminogen activator
GB8726683D0 (en) Tissue plasminogen activator
GB8725052D0 (en) Tissue plasminogen activator

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19921127

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20081104